NYSE - Nasdaq Real Time Price USD

Laboratory Corporation of America Holdings (LH)

198.40 +0.05 (+0.03%)
At close: April 26 at 4:00 PM EDT
199.14 +0.74 (+0.37%)
After hours: April 26 at 6:55 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
12,161,600.00
12,161,600.00
11,863,900.00
13,136,100.00
13,978,500.00
Cost of Revenue
8,796,700.00
8,796,700.00
8,155,000.00
8,143,700.00
9,025,700.00
Gross Profit
3,364,900.00
3,364,900.00
3,708,900.00
4,992,400.00
4,952,800.00
Operating Expense
2,241,200.00
2,241,200.00
1,956,700.00
1,919,800.00
2,004,700.00
Operating Income
1,123,700.00
1,123,700.00
1,752,200.00
3,072,600.00
2,948,100.00
Net Non Operating Interest Income Expense
-199,600.00
-199,600.00
-179,800.00
-211,800.00
-207,400.00
Other Income Expense
-355,200.00
-355,200.00
-335,000.00
26,800.00
-521,600.00
Pretax Income
568,900.00
568,900.00
1,237,400.00
2,887,600.00
2,219,100.00
Tax Provision
188,500.00
188,500.00
233,900.00
690,000.00
662,100.00
Net Income Common Stockholders
418,000.00
418,000.00
1,279,100.00
2,377,300.00
1,556,100.00
Diluted NI Available to Com Stockholders
418,000.00
418,000.00
1,279,100.00
2,377,300.00
1,556,100.00
Basic EPS
4.80
4.80
14.05
24.60
15.99
Diluted EPS
4.77
4.77
13.97
24.39
15.88
Basic Average Shares
87,100.00
87,100.00
91,100.00
96,700.00
97,300.00
Diluted Average Shares
87,600.00
87,600.00
91,600.00
97,500.00
98,000.00
Total Operating Income as Reported
725,600.00
725,600.00
1,436,500.00
3,048,600.00
2,445,400.00
Total Expenses
11,037,900.00
11,037,900.00
10,111,700.00
10,063,500.00
11,030,400.00
Net Income from Continuing & Discontinued Operation
418,000.00
418,000.00
1,279,100.00
2,377,300.00
1,556,100.00
Normalized Income
626,261.70
626,261.70
1,251,950.20
2,206,967.20
1,901,764.80
Interest Expense
199,600.00
199,600.00
179,800.00
211,800.00
207,400.00
Net Interest Income
-199,600.00
-199,600.00
-179,800.00
-211,800.00
-207,400.00
EBIT
768,500.00
768,500.00
1,417,200.00
3,099,400.00
2,426,500.00
EBITDA
1,345,800.00
1,345,800.00
1,954,400.00
3,676,400.00
3,051,200.00
Reconciled Cost of Revenue
8,439,200.00
8,439,200.00
7,811,400.00
7,796,200.00
8,676,400.00
Reconciled Depreciation
577,300.00
577,300.00
537,200.00
577,000.00
624,700.00
Net Income from Continuing Operation Net Minority Interest
379,200.00
379,200.00
1,002,000.00
2,195,400.00
1,556,100.00
Total Unusual Items Excluding Goodwill
-369,300.00
-369,300.00
-308,200.00
-15,200.00
-492,400.00
Total Unusual Items
-369,300.00
-369,300.00
-308,200.00
-15,200.00
-492,400.00
Normalized EBITDA
1,715,100.00
1,715,100.00
2,262,600.00
3,691,600.00
3,543,600.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-122,238.30
-122,238.30
-58,249.80
-3,632.80
-146,735.20
12/31/2020 - 3/29/1990

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DGX Quest Diagnostics Incorporated
134.26
-0.86%
 
NVTAQ Invitae Corporation
0.0005
-94.44%
 
TMO Thermo Fisher Scientific Inc.
573.60
+0.33%
 
DHR Danaher Corporation
246.58
+0.32%
 
ICLR ICON Public Limited Company
308.31
+2.74%
 
CRL Charles River Laboratories International, Inc.
229.03
+0.54%
 
IQV IQVIA Holdings Inc.
234.88
+0.38%
 
MEDP Medpace Holdings, Inc.
395.93
+1.58%
 
WAT Waters Corporation
311.30
+0.96%
 
EXAS Exact Sciences Corporation
58.85
+0.10%